![Peter K. Schulz-Knappe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter K. Schulz-Knappe
Plus aucun poste en cours
Historique de carrière de Peter K. Schulz-Knappe
Anciens postes connus de Peter K. Schulz-Knappe
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNOVIA AB | Directeur Technique/Scientifique/R&D | - | 31/08/2020 |
PROTEOME SCIENCES PLC | Directeur Technique/Scientifique/R&D | 05/10/2009 | 31/12/2009 |
Protagen AG
![]() Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2010 | - |
Corporate Officer/Principal | 05/05/2010 | 23/12/2014 | |
Digilab BioVisioN GmbH
![]() Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Directeur Technique/Scientifique/R&D | 01/11/1997 | - |
Fondateur | 01/11/1997 | - |
Statistiques
Internationale
Allemagne | 3 |
Royaume-Uni | 2 |
Suède | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
PROTEOME SCIENCES PLC | Health Technology |
IMMUNOVIA AB | Health Technology |
Entreprise privées | 2 |
---|---|
Digilab BioVisioN GmbH
![]() Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Commercial Services |
Protagen AG
![]() Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |
- Bourse
- Insiders
- Peter K. Schulz-Knappe
- Expérience